In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

The Medicines Co., Nycomed in Angiomax agreement

Executive Summary

Nycomed Danmark (private company owned by equity group that manufactures and markets drugs and consumer health products) will exclusively distribute The Medicines Co.'s cardiovascular drug Angiomax (bivalirudin) in 35 countries including 12 in Europe.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register